Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 491.058 million compared to CNY 499.999 million a year ago. Operating income was CNY 255.675 million compared to CNY 283.123 million a year ago. Net income was CNY 229.130 million compared to CNY 246.581 million a year ago. Basic earnings per share from continuing operations was CNY 0.4376 compared to CNY 0.471 a year ago.